“…2017 ([2017] EWHC 13 (Pat)) (“the First Judgment”), referred to the Court of Justice of the European Union (“CJEU”) the following question for a preliminary ruling: “What are the criteri…”
“…In Teva UK v Gilead Sciences Inc [2017] EWHC 13 (Pat), Arnold J made a further reference to the CJEU. In that case the SPC was for a combination product consisting of two active ingredients, namely (i) tenofovir d…”